Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid

J Soc Gynecol Investig. 1998 Jan-Feb;5(1):44-7. doi: 10.1016/s1071-5576(97)00097-x.

Abstract

Objective: To evaluate the levels of mRNA for the extracellular matrix proteins collagen type I, collagen type III, and fibronectin in leiomyomas and myometrium obtained from women treated with GnRH-agonist (GnRH-a) and to examine steroid hormone regulation of these proteins using an in vitro explant culture system.

Methods: Northern blot analysis of mRNA was obtained from hysterectomy specimens at the time of surgery or after 48 hours of in vitro steroid treatment. A portion of the tissue was processed for RNA, and the remaining tissue was used to establish explant cultures. Extracellular matrix/alpha-tubulin ratio was computed for each band, and within each experiment the lowest ratio was standardized to a value of one densitometry unit to allow for comparison among experiments.

Results: There is a relative overexpression of both collagen type I and collagen type III mRNAs but not fibronectin in leiomyomas compared to myometrium from the same uteri of women treated with GnRH-a.

Conclusion: Leiomyomas obtained from women treated with GnRH-a show an up-regulation of collagens type I and type III similar to that seen in leiomyomas obtained from women in the proliferative phase of their menstrual cycles.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Collagen / analysis*
  • Collagen / classification
  • Collagen / genetics
  • Densitometry
  • Female
  • Fibronectins / analysis
  • Fibronectins / genetics
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Leiomyoma / drug therapy*
  • Leiomyoma / metabolism
  • Leiomyoma / pathology
  • Leuprolide / pharmacology
  • Leuprolide / therapeutic use*
  • Myometrium / chemistry*
  • Myometrium / pathology
  • RNA, Messenger / analysis
  • RNA, Messenger / biosynthesis
  • Tubulin / analysis
  • Tubulin / genetics
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / metabolism
  • Uterine Neoplasms / pathology

Substances

  • Antineoplastic Agents, Hormonal
  • Fibronectins
  • RNA, Messenger
  • Tubulin
  • Collagen
  • Leuprolide